Wellington owns almost 5% of Genmab shares

On Tuesday, the asset manager has informed the Danish biotech firm that it owns 4.98% of Genmab stock.

Photo: Joost Melis / Genmab / PR

Asset manager Wellington Management Group has an ownership stake of 4.98% in Genmab, the Danish biotech firm reported in a press release Tuesday.

Last time Wellington reported its assets, in late July, it said it had decreased its share holding in Genmab to 4.9%.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs